Bullish option flow detected in BridgeBio (BBIO) Pharma with 4,472 calls trading, 2.0x expected, and implied vol increasing over 2 points to 47.13%. May-25 30 calls and May-25 40 calls are the most active options, with total volume in those strikes near 2,700 contracts. The Put/Call Ratio is 0.09. Earnings are expected on July 31st.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBIO:
- Biotech Alert: Searches spiking for these stocks today
- BridgeBio Pharma’s Strong Financial Performance and Promising Pipeline Justify Buy Rating
- BridgeBio Pharma Stock (BBIO) Jumps on Strong Drug Launch
- BridgeBio Pharma’s Earnings Call Highlights Success and Growth
- BridgeBio price target raised to $55 from $52 at Scotiabank